Yuqin Song

Burden of lymphoma in China, 1990−2019: an analysis of the global burden of diseases, injuries, and risk factors study 2019

Jun Zhu, Lijun Wang, Jiangmei Liu, 2022, Aging.

BURDEN OF LYMPHOMA IN CHINA, 1990−2019: AN ANALYSIS OF GLOBAL BURDEN OF DISEASES, INJURIES, AND RISK FACTORS STUDY 2019

D. Zhao, Li-ping Wang, Jiangmei Liu, 2021, Hematological Oncology.

Phase 1 clinical trial of the PI3Kδ inhibitor YY-20394 in patients with B-cell hematological malignancies

L. Qiu, Yuqin Song, Bo Jiang, 2021, Journal of Hematology & Oncology.

Parallel Comparison of 4-1BB or CD28 Co-stimulated CD19-Targeted CAR-T Cells for B Cell Non-Hodgkin’s Lymphoma

T. He, Jun Zhu, N. Lin, 2019, Molecular therapy oncolytics.

415. First-In-Patient Proof of Safety and Efficacy of a 4th Generation Chimeric Antigen Receptor-Modified T Cells for the Treatment of Relapsed or Refractory CD30 Positive Lymphomas

Lung-Ji Chang, Jun Zhu, N. Lin, 2015 .